{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T19:37:04Z","timestamp":1703014624515},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T00:00:00Z","timestamp":1533254400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s00063-018-0453-7","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T10:50:03Z","timestamp":1533293403000},"page":"101-106","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Inhalative Analgosedierung auf der Intensivstation"],"prefix":"10.1007","volume":"115","author":[{"given":"W.","family":"Klingler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Pfenninger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,3]]},"reference":[{"key":"453_CR1","volume-title":"S3-Leitlinie. Analgesie, Sedierung und Delirmanagement in der Intensivmedizin (DAS-Leitlinie 2015). AWMF-Registernummer: 001\/012","author":"AWMF","year":"2015","unstructured":"AWMF (2015) S3-Leitlinie. Analgesie, Sedierung und Delirmanagement in der Intensivmedizin (DAS-Leitlinie 2015). AWMF-Registernummer: 001\/012"},{"issue":"3","key":"453_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/1944451613479400","volume":"4","author":"AF Bautista","year":"2013","unstructured":"Bautista AF, Tongprasert S (2013) Malignant hyperthermia or not malignant hyperthermia: a diagnostic conundrum. ICU Dir 4(3):143\u2013146","journal-title":"ICU Dir"},{"key":"453_CR3","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/bja\/aev225","volume":"115","author":"P Hopkins","year":"2015","unstructured":"Hopkins P, Ruffert H, Snoeck M, Girard T, Glahn K, Ellis F, Muller C, Urwyler A, Bandschapp O, Gillies R, Glauber V, Heytens L, Islander G, Klingler W, Kraft B, Krivosic-Horber R, Pollock N, Schuster F, Silva H, Sorrentino V, Street N, Tegazzin V, Tzanova I, European Malignant Hyperthermia Group collaborators (2015) European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility. Br J Anaesth 115:531\u2013539","journal-title":"Br J Anaesth"},{"key":"453_CR4","volume-title":"Intensivmedizinische Versorgung in Krankenh\u00e4usern in der Region Deutschland","author":"Gesundheitsberichtserstattung des Bundes","year":"2017","unstructured":"Gesundheitsberichtserstattung des Bundes (2017) Intensivmedizinische Versorgung in Krankenh\u00e4usern in der Region Deutschland. \nhttp:\/\/www.gbe-bund.de\/oowa921-install\/servlet\/oowa\/aw92\/dboowasys921.xwdevkit\/xwd_init?gbe.isgbetol\/xs_start_neu\/&p_aid=i&p_aid=76704028&nummer=838&p_sprache=D&p_indsp=99999999&p_aid=29347479\n\n. Zugegriffen: 13. Febr. 2017"},{"issue":"4","key":"453_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/bja\/aeq243","volume":"105","author":"KPE Glahn","year":"2010","unstructured":"Glahn KPE, Ellis FR, Halsall PJ, Halsall J, M\u00fcller CR, Snoeck J, Urwyler A, Wappler F (2010) Recognizing and managing a\u00a0malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group. Br J Anaesth 105(4):417\u2013420","journal-title":"Br J Anaesth"},{"key":"453_CR6","volume-title":"Urteil AZ 3\u00a0U\u00a04\/06","author":"OLG Hamm","year":"2006","unstructured":"Hamm OLG Urteil, 20.09.2006, AZ 3\u00a0U\u00a04\/06"},{"key":"453_CR7","first-page":"70","volume-title":"Fehler und Irrt\u00fcmer in der Intensivmedizin","author":"W Heinrichs","year":"2017","unstructured":"Heinrichs W (2017) Maligne Hyperthermie bei Sepsis und Sedierung mit dem AnaConDa\u00ae-System. In: Meybohm P, Muellenbach RM, Heinrichs W, Schalk R, Stehr S (Hrsg) Fehler und Irrt\u00fcmer in der Intensivmedizin. Thieme, Stuttgart, New York, S 70\u201371"},{"key":"453_CR8","doi-asserted-by":"publisher","first-page":"A11","DOI":"10.1186\/1471-2253-14-S1-A11","volume":"14","author":"S Johannsen","year":"2014","unstructured":"Johannsen S, M\u00f6gele S, Roewer N, Schuster F (2014) Malignant hyperthermia on ICU\u2014sudden attack of the \u201esnake\u201c. BMC Anesthesiol 14:A11","journal-title":"BMC Anesthesiol."},{"key":"453_CR9","first-page":"913","volume-title":"Neuromuscular disorders of infancy, childhood and adolescence","author":"W Klingler","year":"2014","unstructured":"Klingler W, Lehmann-Horn F (2014) Malignant hyperthermia: an inherited disorder of muscle calcium metabolism. In: Darras BT, Jones HR Jr, Ryan MM, Darryl C (Hrsg) Neuromuscular disorders of infancy, childhood and adolescence. Elsevier, Amsterdam, S 913\u2013920"},{"key":"453_CR10","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s00101-016-0167-2","volume":"5","author":"W Klingler","year":"2016","unstructured":"Klingler W, Pfenninger E (2016) Pharmakogenetik in An\u00e4sthesie und Intensivmedizin. Anaesthesist 5:380\u2013389","journal-title":"Anaesthesist"},{"key":"453_CR11","first-page":"201","volume":"59","author":"W Klingler","year":"2018","unstructured":"Klingler W, Roewer N, Schuster F, Wappler F (2018): S1-Leitlinie: Therapie der malignen Hyperthermie. AWMF-Register-Nr. 001\/008. An\u00e4sth Intensivmed;59:204\u2013208","journal-title":"An\u00e4sth Intensivmed"},{"key":"453_CR12","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1365-2044.2004.03658.x","volume":"59","author":"T Krause","year":"2004","unstructured":"Krause T, Gerbershagen MU, Fiege M, Wei\u00dfhorn R, Wappler F (2004) Dantrolene: a\u00a0review on pharmacology, therapeutic use and new developments. Anaesthesia 59:364\u2013373","journal-title":"Anaesthesia"},{"key":"453_CR13","volume-title":"Merkblatt: \u201eZur \u00e4rztlichen Schweigepflicht\u201c, Stand Oktober 2009","author":"Landes\u00e4rztekammer Baden-W\u00fcrttemberg","year":"2009","unstructured":"Landes\u00e4rztekammer Baden-W\u00fcrttemberg Merkblatt: \u201eZur \u00e4rztlichen Schweigepflicht\u201c, Stand Oktober 2009. \nhttps:\/\/www.aerztekammer-bw.de\/10aerzte\/40merkblaetter\/10merkblaetter\/schweigepflicht.pdf\n\n. Zugegriffen: 24. Jan. 2016"},{"issue":"5","key":"453_CR14","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1097\/ALN.0b013e318232008f","volume":"115","author":"F Lehmann-Horn","year":"2011","unstructured":"Lehmann-Horn F, Klingler W, Jurkat-Rott K (2011) Nonanesthetic malignant hyperthermia. Anesthesiology 115(5):915\u2013917","journal-title":"Anesthesiology"},{"issue":"6258","key":"453_CR15","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/343562a0","volume":"343","author":"T McCarthy","year":"1990","unstructured":"McCarthy T, Healy J, Heffron J, Lehane M, Deufel T, Lehmann-Horn F, Farrall M, Johnson K (1990) Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2. Nature 343(6258):562\u2013564","journal-title":"Nature"},{"key":"453_CR16","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1007\/s00101-014-2392-x","volume":"63","author":"T Metterlein","year":"2014","unstructured":"Metterlein T, Schuster F, Graf BM, Anetseder M (2014) Maligne Hyperthermie. An\u00e4sthesist 63:908\u2013918","journal-title":"An\u00e4sthesist"},{"key":"453_CR17","volume-title":"Urteil vom 30.11.2006, Az. 5\u202fU 209\/06","author":"OLG Koblenz","year":"2006","unstructured":"OLG Koblenz (2006) Urteil vom 30.11.2006, Az. 5\u202fU 209\/06"},{"key":"453_CR18","volume-title":"Urteil vom 09. 11. 1988","author":"OLG K\u00f6ln","year":"1988","unstructured":"OLG K\u00f6ln (1988) Urteil vom 09. 11. 1988"},{"key":"453_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13023-015-0310-1","volume":"10","author":"H Rosenberg","year":"2015","unstructured":"Rosenberg H, Pollock N, Schiemann A, Bulger T, Stowell K (2015) Malignant hyperthermia: a\u00a0review. Orphanet J Rare Dis 10:93","journal-title":"Orphanet J Rare Dis"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-018-0453-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00063-018-0453-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-018-0453-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T14:14:32Z","timestamp":1583504072000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00063-018-0453-7"}},"subtitle":["Gefahr einer malignen Hyperthermie"],"short-title":[],"issued":{"date-parts":[[2018,8,3]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["453"],"URL":"https:\/\/doi.org\/10.1007\/s00063-018-0453-7","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,3]]},"assertion":[{"value":"14 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Die Maligne Hyperthermie Hotline Deutschland vertreten durch Prof. Dr. Klingler wird durch die Fa. Norgine gef\u00f6rdert. Prof. Dr. Pfenninger und Prof. Dr. Klingler erhielten Referentenhonorare von der Fa. Norgine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}